Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Essential resource for top-line data and analysis covering the Russia pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2016 annual average exchange rates. - The Russian pharmaceuticals market had total revenues of $16.7bn in 2016, representing a compound annual growth rate (CAGR) of 19.9% between 2012 and 2016. - Compulsory licensing, if implemented, could deter development because patents taken outside of Russia would have reduced value as the government could harm the revenues of foreign companies. In 2016, however, reports surfaced that enthusiasm had dropped within the Kremlin for the policy. - The Russian market is largely controlled by the commercial segment, rather than government purchasing. In contrast, the majority of EU countries compensate 65-80 percent of patients’ expenses incurred on purchasing most prescribed medicines.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Russia - Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Russia - Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance - Add weight to presentations and pitches by understanding the future growth prospects of the Russia pharmaceuticals market with five year forecasts
Reasons to buy
- What was the size of the Russia pharmaceuticals market by value in 2016? - What will be the size of the Russia pharmaceuticals market in 2021? - What factors are affecting the strength of competition in the Russia pharmaceuticals market? - How has the market performed over the last five years? - Who are the top competitiors in Russia’s pharmaceuticals market?
Our reports have been used by over 10K customers, including:
Spending on medicines and healthcare in Russia witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/ expansion opportunities. Both Pharmaceutical sales and consumption are on rise and the outlook to 2025 remains robust driven by strong pharmaceutical market fundamentals. The...
Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide 2013-2022 Summary The BRIC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions...
Pharmaceuticals Global Group of Eight (G8) Industry Guide 2013-2022 Summary The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions...
BRIC Peripheral Vascular Devices Market Outlook to 2025 Summary GlobalData’s new report, BRIC Peripheral Vascular Devices Market Outlook to 2025, provides key market data on the BRIC Peripheral Vascular Devices market. The report provides value, in millions of US dollars, volume (in units) and average...